Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 1/20 | 0.46 |
| ▸ | CNR2 | P34972 | 1/20 | 0.46 |
| ▸ | ABL1 | P00519 | 1/20 | 0.43 |
| ▸ | EIF4E | P06730 | 10/20 | 0.40 |
| ▸ | EPHB4 | P54760 | 2/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | NTMT1 | Q9BV86 | 1/20 | 0.37 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21652242 | 0.88 | CNR1 (0.46) | CNR1CNR2ABL1EIF4ENTMT1 | |
| SCHEMBL19625377 | 0.86 | CNR1 (0.48) | CNR1CNR2ABL1EIF4E | |
| SCHEMBL21652239 | 0.86 | RAB9A (0.46) | CNR1CNR2EIF4ETP53NTMT1 | |
| SCHEMBL17124797 | 0.81 | GFER (0.53) | CNR1CNR2TP53NTMT1 | |
| SCHEMBL2662446 | 0.80 | ABL1 (0.46) | ABL1EIF4EEPHB4NISCH | |
| SCHEMBL21652287 | 0.79 | CNR1 (0.46) | CNR1CNR2ABL1EIF4ENTMT1 | |
| SCHEMBL21652283 | 0.79 | CYP19A1 (0.48) | CNR1CNR2ABL1 | |
| SCHEMBL21652162 | 0.78 | KDM4E (0.51) | CNR1CNR2TP53NTMT1 | |
| SCHEMBL13996110 | 0.77 | ABL1 (0.43) | ABL1EIF4EEPHB4NISCH | |
| SCHEMBL21652282 | 0.76 | KDM4E (0.52) | CNR1CNR2TP53NTMT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10544092-B2 | Malononitrile oxime ether compound and use thereof | SHENYANG SINOCHEM AGROCHEMICALS R&D CO., LTD. (CN) | 2020-01-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10544092-B2 | Malononitrile oxime ether compound and use thereof | ME1, MAL2, ME3 | CNR1 2295/4885CNR2 2550/4885ABL1 3029/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.